Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT04295330
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
260
Enrollment
OTHER
Sponsor class
Conditions
Primary Liver Cancer
Interventions
DRUG:
Lidocaine Hydrochloride, Injectable
DRUG:
0.9% normal saline
Sponsor
West China Hospital